Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech — Stella

Home/PPA/Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

View on ClinicalTrials.gov

Recruiting

Back to PPA trials

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Mayo Clinic, Rochester, Minnesota

Key details

Phase

Post-approval study

Sponsor

Mayo Clinic

Collaborators

National Institute on Deafness and Other Communication Disorders (NIDCD)

Enrollment target

~50 participants

Started

July 2018

Primary completion

June 2028

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.